Decipher Labs Ltd. (DECIPHER.BO) stock plunged 20.00% to INR 5.92 on the BSE after hours on 03 Mar 2026, marking a one‑day rout that left the share at its year low. The move came on a volume spike of 97,364 shares versus an average of 6,337, a 15.36x increase that points to thin‑market volatility. Healthcare sector weakness (sector 1D -2.0%) and limited liquidity amplified losses. This article breaks down the price action, fundamentals, technicals, Meyka AI grade and forecast, and practical price targets for traders and longer‑term investors.

DECIPHER.BO stock price action and immediate drivers

The main driver was a liquidity shock: volume 97,364 vs avgVolume 6,337 produced heavy selling and a -20.00% drop to INR 5.92 on BSE after hours. Trade opened at INR 5.93 and the intraday high was INR 6.44, so selling pressure hit late in the session. No company press release explains the fall, so the move reads as profit taking and stop‑loss cascade in a low‑float stock.

Fundamentals snapshot for DECIPHER.BO stock

Decipher Labs Ltd. lists market cap INR 59,792,000.00, EPS -7.98 and reported PE -0.74, showing current negative earnings. Balance sheet strengths include book value per share INR 19.05, cash per share INR 2.39, and current ratio 4.14, while debt is low with debt/equity 0.02. On revenue metrics the price/sales 0.36 and price/book 0.31 indicate deep value if earnings recover, but margins are negative and ROE is -37.53%.

Technical outlook and levels for DECIPHER.BO stock

Technicals show oversold momentum: RSI 26.45, CCI -234.48, and Williams %R -100.00, flagging short‑term exhaustion but little sign of immediate reversal. Key levels: near‑term support is INR 5.92 (day and year low) and resistance clusters sit at INR 6.78 (Bollinger lower band) and INR 8.01 (Bollinger middle). Volatility measures show ATR 0.50, so expect wide intraday swings while liquidity remains thin.

Meyka AI grade and DECIPHER.BO stock forecast

Meyka AI rates DECIPHER.BO with a score out of 100: 61.43 / 100 (Grade B), suggestion HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 1‑month price of INR 7.43, implying a 25.51% upside from the current INR 5.92; forecasts are model‑based projections and not guarantees.

Valuation, risks and sector context

Valuation looks attractive by multiple ratios: PB 0.31, P/S 0.36, and low enterprise value to sales 0.34. Key risks are continued negative earnings (EPS -7.98), poor profitability margins (net margin -48.99%), very low liquidity, and slow receivables (DSO 71.87). Healthcare peers showed modest weakness today, with sector 1D -2.0%, which compounds pressure on small pharma names like Decipher Labs.

Trading strategy and price targets for DECIPHER.BO stock

For short traders, watch available liquidity and set tight stops below INR 5.92 to limit gap risk. A conservative intraday recovery target is INR 7.50 (near the Meyka one‑month forecast INR 7.43). A downside scenario uses a longer‑term target of INR 3.37 (yearly model forecast) implying large downside should earnings fail to recover. Link for live quotes and history: Decipher Labs on Meyka. For macro peer context see MarketWatch pharma listings Edwards Lifesciences and Viatris source.

Final Thoughts

DECIPHER.BO stock closed after hours on 03 Mar 2026 at INR 5.92, down 20.00%, driven by a liquidity‑led selloff and sector weakness. The company shows value signals in PB 0.31 and P/S 0.36, but earnings remain negative with EPS -7.98 and ROE -37.53%, so recovery depends on margin improvement and better trading liquidity. Meyka AI’s short‑term model projects INR 7.43 in one month, an implied 25.51% upside, while the one‑year model sits at INR 3.37, implying downside risk. Traders should treat the stock as high volatility and set tight risk controls; longer‑term investors need clear earnings improvement before adding size. Remember, Meyka AI provides these grades and forecasts as model‑based market analysis and not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.